Ads
-
Related paper
- Stereotactic Body Radiation Therapy for Early - Stage, Inoperable Non-Small Cell Lung Cancer
- FULL ASSESSMENT OF RADIATION THERAPY RESULTS OF DIFFERENT FRACTIONATION REGIMES CHEMOMODIFICATION AMONG III STAGE NON-SMALL-CELL LUNG CANCER PATIENTS
- THE CONTENT OF VEGF, COX-2 AND PGE-2 DEPENDING ON THE OBJECTIVE RESPONSE TO RADIATION THERAPY IN COMBINATION WITH A COX-2 INHIBITOR IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
- A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus
- Volumetric and Dosimetric Influences of Internal Target Delineation Based on 4D CT Measured Tumor Motion in the Treatment of Lung Cancer with Stereotactic Body Radiotherapy
- Influence of Dose Calculation Algorithm According to Dose Prescription Methods in Stereotactic Body Radiotherapy for Lung Cancer
- Suppression of MiR130a-3p Using CRISPR/Cas9 Induces Proliferation and Migration of Non-Small Cell Lung Cancer Cell Line
- MicroRNA-124 Suppresses Tumor Cell Proliferation and Invasion by Targeting CD164 Signaling Pathway in Non-Small Cell Lung Cancer
- Brigatinib treatment for primary lung lesions in non-small-cell lung cancer based on ALK gene rearrangement detected in resected brain metastases: A case report and literature review
- Quercetin Down-regulates IL-6/STAT-3 Signals to Induce Mitochondrial-mediated Apoptosis in a Non-small-cell Lung-cancer Cell Line, A549